| Schedule of earning per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended
June 30,
2026 |
|
|
Three months ended
June 30,
2025 |
|
|
Six months ended
June 30,
2026 |
|
|
Six months ended
June 30,
2025 |
|
| Net loss attributable to common stockholders |
|
|
(4,919,849 |
) |
|
|
(445,105 |
) |
|
|
(5,738,528 |
) |
|
|
(445,105 |
) |
| Weighted-average
common shares — basic |
|
|
38,274,849 |
|
|
|
7,522,653 |
|
|
|
29,265,646 |
|
|
|
7,522,653 |
|
| Dilutive effect of warrants, options and RSUs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Weighted-average
common shares — diluted |
|
|
38,274,849 |
|
|
|
7,522,653 |
|
|
|
29,265,646 |
|
|
|
7,522,653 |
|
| Net
loss per share — basic |
|
$ |
(0.13 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.06 |
) |
| Net
loss per share — diluted |
|
$ |
(0.13 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.06 |
) |